Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid-to-late pregnancy loss

The Journal of Obstetrics and Gynaecology Research
T SugiT Makino

Abstract

Associations have been reported between antiphospholipid antibodies (aPL), mainly anticardiolipin antibodies (aCL) and/or the lupus anticoagulant, and recurrent pregnancy losses (RPL). However, relatively few studies describing antiphosphatidylethanolamine antibodies (aPE) have been reported. We describe the prevalence of aPL to both cardiolipin and phosphatidylethanolamine in patients with RPL. Patients with recurrent early pregnancy losses (n = 145) and mid-to-late pregnancy loss(es) (n = 26) were screened for aPE and aCL. In patients with recurrent early pregnancy losses, prevalence of immunoglobulin G (IgG) aPE (17.9%, P = 0.001) and immunoglobulin M (IgM) aPE (12.4%, P = 0.01) was significantly higher than in the control group. In patients with mid-to-late pregnancy loss(es), prevalence of IgM aPE (19.2%, P = 0.008) and IgG aCL (23.1%, P = 0.02) was significantly higher than in the control group. Our data suggest that aPE may be a risk factor in patients with mid-to-late pregnancy loss(es) as well as recurrent early pregnancy losses.

References

Sep 1, 1992·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·N SchacharL McGann
Jan 1, 1991·Advances in Immunology·H P McNeilS A Krilis
Jan 1, 1990·The American Journal of Pediatric Hematology/oncology·M AndrewM Johnston
Feb 1, 1989·Annals of the Rheumatic Diseases·H L StaubG R Hughes
Jul 1, 1986·The Journal of Clinical Investigation·E J GustafsonA H Schmaier
Nov 21, 1985·The New England Journal of Medicine·D W BranchE Hershgold
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·J KatsunumaT Makino

❮ Previous
Next ❯

Citations

Nov 22, 2009·Amino Acids·Ming Zhao
Oct 6, 2007·Clinical Reviews in Allergy & Immunology·H J A Carp, Y Shoenfeld
Mar 19, 2013·Rheumatology·Rabih NayfeMunther A Khamashta
Nov 12, 2009·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis· Zhixin Li Ming Zhao
Nov 10, 2010·Current Rheumatology Reports·Marielle Sanmarco
May 14, 2014·Autoimmunity Reviews·Silvia D'IppolitoNicoletta Di Simone
Apr 13, 2010·Journal of Immunological Methods·Marielle Sanmarco
Feb 13, 2009·Journal of Reproductive Immunology·Hideto YamadaHisanori Minakami
Feb 20, 2009·European Journal of Haematology·Katrien Devreese, Marc F Hoylaerts
Sep 11, 2008·American Journal of Reproductive Immunology : AJRI·Jaume Alijotas-ReigLluis Cabero-Roura
Feb 13, 2013·American Journal of Reproductive Immunology : AJRI·Shanmugam VelayuthaprabhuGovindaraju Archunan
Jun 1, 2011·American Journal of Reproductive Immunology : AJRI·Shanmugam VelayuthaprabhuGovindaraju Archunan
Sep 15, 2012·The Journal of Dermatology·Minoru HasegawaKazuhiko Takehara
Aug 22, 2006·Autoimmunity Reviews·Ricard CerveraMarie-Claire Boffa
Jan 31, 2012·Journal of Autoimmunity·Howard J A CarpYehuda Shoenfeld
Jul 17, 2012·Autoimmunity Reviews·Henrique Luiz StaubMunther A Khamashta
Dec 30, 2014·La Presse médicale·Cécile Marie YelnikMarc Lambert
Aug 15, 2006·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Chris GardinerIan J Mackie
Jul 25, 2006·The Journal of Biological Chemistry·Yong TianSuzanne Jackowski
Aug 1, 2013·Expert Review of Clinical Immunology·Bassem N MattaMunther A Khamashta
May 28, 2019·Acta Obstetricia Et Gynecologica Scandinavica·Jinfeng XuBing Peng
Jul 4, 2013·Southern Medical Journal·Pramod Reddy
Jul 18, 2009·Reproductive Medicine and Biology·Hidehiko Matsubayashi
Jun 18, 2020·Reproductive Sciences·Mirei YonezawaToshiyuki Takeshita
Aug 14, 2019·Journal of Clinical Laboratory Analysis·Hongyuan ZhuZheng Cao
Mar 3, 2020·La Revue de médecine interne·V Salle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.